Boehringer Ingelheim Fonds Call for Applications: Travel Grants
The Boehringer Ingelheim Fonds (BIF) awards travel grants of up to three months duration to MD and PhD students, as well as postdoctoral researchers from all over the world.
The grant supports junior scientists who want to learn clearly-defined methods useful for their ongoing research and their current laboratory by
- Visiting another laboratory
- Attending research-orientated courses with the practical part making up at least 50 % of the course.
They can also be used by PhD candidates and their potential supervisors to evaluate the scientific and personal fit before the start of a PhD project in another country by funding a research stay of one to three months in the supervisor’s laboratory.
Who can apply?:
- PhD students or medical students during their doctoral thesis as well as postdocs. In addition, we support research visits of graduates who have applied for a PhD project abroad, but who have not yet worked with their potential PhD supervisor and not yet obtained a Phd position (hereafter called PhD candidates).
- European citizens working in Europe and overseas, and to non-European citizens who perform their MD, PhD or postdoctoral project in Europe, or will use the travel grant to work in Europe.
Funding details:
- BIF’s travel grants (lump sum) contribute to the expenses for travel to and from your destination, lodging (e.g. student housing), and course fees. Since we expect your home institution to continue to pay your salary, travel grants do not cover costs for living expenses, local travel during the stay, visa, or insurance.
- For doctoral students and postdoc applicants from countries with very low incomes, additional funds for living costs may be granted. Please refer to FAQs for more information.
Applications for travel grants may be submitted at any time, but must reach the Boehringer Ingelheim Fonds (BIF) at the latest six weeks prior, but not earlier than six months before your proposed departure date.
Read more here.
Application deadline ongoing.
